Hill Stephen J. - Insider Non-Derivative Transactions at Lyell Immunopharma, Inc. (LYEL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 10, 2025, Hill Stephen J.'s relationship to Lyell Immunopharma, Inc. (LYEL) is Officer (Chief Operating Officer), and currently has 15,750 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LYEL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Hill Stephen J. - Insider Non-Derivative Transactions of LYEL Common Stock

Hill Stephen J. - Insider Non-Derivative Transactions at LYEL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 11, 2025	Sell -- (Common Stock)	95	16.12	15750
Aug 22, 2025	Sell -- (Common Stock)	1004	10.54	15845
Aug 21, 2025	Acquisition -- (Common Stock)	8000	0	16849
Aug 13, 2025	Sell -- (Common Stock)	94	10.34	8849
Aug 12, 2025	Sell -- (Common Stock)	91	10.53	8943
Feb 11, 2025	Acquisition -- (Common Stock)	112500	0	172899
Feb 10, 2024	Acquisition -- (Common Stock)	40000	0	48928